National Bank of Canada’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,647
Closed -$11.4K 2865
2024
Q1
$11.4K Buy
18,647
+3,800
+26% +$4.29K ﹤0.01% 2142
2023
Q4
$24.5K Sell
14,847
-160
-1% -$234 ﹤0.01% 1958
2023
Q3
$21.8K Sell
15,007
-480
-3% -$1.2K ﹤0.01% 2020
2023
Q2
$39.9K Sell
15,487
-416
-3% -$1.24K ﹤0.01% 1837
2023
Q1
$58.6K Hold
15,903
﹤0.01% 1671
2022
Q4
$28K Sell
15,903
-4,900
-24% -$13K ﹤0.01% 1922
2022
Q3
$82K Buy
20,803
+16,223
+354% +$99.8K ﹤0.01% 1574
2022
Q2
$25K Buy
4,580
+294
+7% +$2.41K ﹤0.01% 2012
2022
Q1
$63K Sell
4,286
-46
-1% -$616 ﹤0.01% 1816
2021
Q4
$68K Buy
+4,332
New +$104K ﹤0.01% 1753

Other funds holding DMTK

National Bank of Canada's DMTK Position: Q2 2024 in Review

National Bank of Canada sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 18,647 shares — an estimated $11.4K sold.

National Bank of Canada first reported a position in DMTK in Q4 2021 and held it in 10 quarters. The position peaked at $82K in Q3 2022. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • National Bank of Canada reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • National Bank of Canada sold 18,647 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $11.4K.
  • National Bank of Canada first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • National Bank of Canada's DermTech, Inc. Common Stock position peaked at $82K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on National Bank of Canada's 13F filing for Q2 2024, filed 2 Aug 2024.